Clinical trial
IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation System
NCT03700372 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation System
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not reported
- Overall status
- Completed
- Start date
- December 13, 2017
- Completion date
- March 3, 2021
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal atrial fibrillation